{"schema_version":"1","generated_at":"2026-10-28T07:13:34.183Z","data_as_of":null,"url":"https://www.findmykol.com/kol/john-sarantopoulos","json_url":"https://www.findmykol.com/kol/john-sarantopoulos/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"john-sarantopoulos","name":"John Sarantopoulos","credential":"MD","title":"Assistant professor of medicine, Division of Hematology-Oncology, UT Health San Antonio","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"San Antonio","state":"TX","region":{"label":"South Central","url":"https://www.findmykol.com/region/south-central"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1861495343"},"summary":"John Sarantopoulos is Assistant professor of medicine, Division of Hematology-Oncology, UT Health San Antonio. ClinicalTrials.gov lists 8 registered studies matched to this name.","overview":{"text":"John Sarantopoulos, M.D., is Assistant professor of medicine, Division of Hematology-Oncology, UT Health San Antonio. It also documents an investigator role on 10 registered clinical trials, industry payments reported by 18 companies, 3 NIH-funded awards (2008–2026).","bullets":["Top research focus: Lymphoma","10 registered trials on ClinicalTrials.gov","Open Payments reporting from 18 companies"],"generated_at":"2026-10-27"},"focus":{"indications":[{"label":"Lymphoma","therapeutic_area":"Oncology","trials":4,"topics":0,"strength":12},{"label":"Hodgkin Disease","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Kidney Cancer / RCC","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Hepatobiliary Cancer","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Leukemia (AML/ALL/CML/CLL)","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Precursor Cell Lymphoblastic Leukemia-Lymphoma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Lymphoma, Non-Hodgkin","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Leukemia, Lymphocytic, Chronic, B-Cell","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Lymphoma, Follicular","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Burkitt Lymphoma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Lymphoma, B-Cell, Marginal Zone","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Waldenstrom Macroglobulinemia","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Mycosis Fungoides","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Sezary Syndrome","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Lymphoma, T-Cell","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Leukemia, Hairy Cell","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Intraocular Lymphoma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Leukemia, Lymphoid","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Leukemia, T-Cell","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Granuloma","therapeutic_area":"Hematology","trials":1,"topics":0,"strength":3},{"label":"Lymphomatoid Granulomatosis","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Neuro-Oncology / Glioma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3}],"research_topics":["Lymphoma","Hodgkin Disease","Burkitt Lymphoma","Hepatobiliary Cancer","Intraocular Lymphoma","Kidney Cancer / RCC","Leukemia (AML/ALL/CML/CLL)","Leukemia, Hairy Cell","Leukemia, Lymphocytic, Chronic, B-Cell","Leukemia, Lymphoid","Leukemia, T-Cell","Lymphoma, B-Cell, Marginal Zone","Lymphoma, Follicular","Lymphoma, Non-Hodgkin","Lymphoma, T-Cell","Lymphomatoid Granulomatosis","Mycosis Fungoides","Neuro-Oncology / Glioma","Precursor Cell Lymphoblastic Leukemia-Lymphoma","Sezary Syndrome","Waldenstrom Macroglobulinemia"],"drugs_studied":{"total":12,"shown":3,"withheld":9,"rows":[{"name":"Cabometyx","generic":"Cabozantinib","trials":0,"payments":263,"publications":0,"mentions":263},{"name":"Braftovi","generic":"Encorafenib","trials":0,"payments":127,"publications":0,"mentions":127},{"name":"Libtayo","generic":"Cemiplimab","trials":0,"payments":84,"publications":0,"mentions":84}]},"works_with":{"total":26,"shown":3,"withheld":23,"rows":[{"name":"Exelixis Inc.","trials":0,"payments":263,"mentions":263},{"name":"Pfizer Inc.","trials":0,"payments":131,"mentions":131},{"name":"Regeneron Healthcare Solutions, Inc.","trials":0,"payments":83,"mentions":83}]}},"scholarship":{"h_index":0,"latest_activity_year":2026,"source":"works"},"trials":{"count":8,"shown":3,"withheld":5,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT07086768","title":"Dose-Escalation and Dose-Expansion Study of BSI-082 Monotherapy and Combined Therapy in Patients With Advanced or Metastatic Solid Tumors","phase":"PHASE1","status":"RECRUITING","role":"Investigator","sponsor":"Lei Zheng","source_url":"https://clinicaltrials.gov/study/NCT07086768","trial_url":"https://www.findmykol.com/trial/NCT07086768"},{"nct":"NCT02575638","title":"Safety Study of Camptothecin-20-O-Propionate Hydrate (CZ48)","phase":"PHASE1","status":"UNKNOWN","role":"Investigator","sponsor":"Cao Pharmaceuticals Inc.","source_url":"https://clinicaltrials.gov/study/NCT02575638"},{"nct":"NCT01945164","title":"XL999 Administered Intravenously to a Subject With Advanced Malignancies","status":"NO_LONGER_AVAILABLE","role":"Investigator","sponsor":"John Sarantopoulos","source_url":"https://clinicaltrials.gov/study/NCT01945164","trial_url":"https://www.findmykol.com/trial/NCT01945164"}],"source":"trials"},"payments":{"company_count":18,"program_years":{"first":2021,"last":null},"rows_total":40,"shown":3,"withheld":37,"rows":[{"payer":"PFIZER INC.","program_year":2025,"amount_usd":33685.16,"payment_count":33,"source_url":"https://openpaymentsdata.cms.gov/search?query=1861495343"},{"payer":"Exelixis Inc.","program_year":2025,"amount_usd":17134.65,"payment_count":24,"source_url":"https://openpaymentsdata.cms.gov/search?query=1861495343"},{"payer":"Regeneron Healthcare Solutions, Inc.","program_year":2025,"amount_usd":6231.44,"payment_count":5,"source_url":"https://openpaymentsdata.cms.gov/search?query=1861495343"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1861495343","source":"payments"},"prescribing":{"data_year":2024,"areas_total":7,"areas_shown":3,"areas":[{"area":"Cancer & immunology","share_pct":56,"classes_total":4,"classes":[{"class":"PD-1 inhibitor","setting":"administered","share_pct":55.1,"drugs":[{"name":"Pembrolizumab","share_pct":100}],"max_beneficiaries":24},{"class":"Cytochrome P450 17A1 Inhibitor","setting":"prescribed","share_pct":0.5,"drugs":[{"name":"Abiraterone Acetate","share_pct":100}],"max_beneficiaries":16}]},{"area":"Metabolism & gastrointestinal","share_pct":26.2,"classes_total":5,"classes":[{"class":"Other antiemetics","setting":"administered","share_pct":19.3,"drugs":[{"name":"Fosaprepitant","share_pct":100}],"max_beneficiaries":15},{"class":"Serotonin-3 Receptor Antagonist","setting":"mixed","share_pct":5.5,"drugs":[{"name":"Ondansetron hydrochloride","share_pct":65.8},{"name":"Palonosetron hcl","share_pct":32.1},{"name":"Ondansetron Hcl","share_pct":2.1}],"max_beneficiaries":null}]},{"area":"Musculoskeletal","share_pct":11.3,"classes_total":2,"classes":[{"class":"RANK Ligand Inhibitor","setting":"administered","share_pct":10.9,"drugs":[{"name":"Denosumab","share_pct":100}],"max_beneficiaries":15},{"class":"Bisphosphonate","setting":"administered","share_pct":0.4,"drugs":[{"name":"Zoledronic acid","share_pct":100}],"max_beneficiaries":13}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":100,"facility_pct":0},"source":"medicare"},"funding":{"award_count":3,"fiscal_years":{"first":2008,"last":2026},"rows_total":10,"shown":3,"withheld":7,"rows":[{"project":"UM1CA186688","title":"Texas EXperimental Cancer Therapeutics Network - TEX CTN","fiscal_year":2026,"amount_usd":1519430,"organization":"UNIVERSITY OF TX MD ANDERSON CAN CTR","source_url":"https://reporter.nih.gov/quickSearch/UM1CA186688"},{"project":"UM1CA186688","title":"Texas EXperimental Cancer Therapeutics Network - TEX CTN","fiscal_year":2025,"amount_usd":1679285,"organization":"UNIVERSITY OF TX MD ANDERSON CAN CTR","source_url":"https://reporter.nih.gov/quickSearch/UM1CA186688"},{"project":"UM1CA186688","title":"Texas EXperimental Cancer Therapeutics Network - TEX CTN","fiscal_year":2024,"amount_usd":1679285,"organization":"UNIVERSITY OF TX MD ANDERSON CAN CTR","source_url":"https://reporter.nih.gov/quickSearch/UM1CA186688"}],"source":"grants"},"presence":{"owned_accounts":{"total":1,"shown":1,"rows":[{"platform":"doximity","url":"https://www.doximity.com/pub/john-sarantopoulos-md","status":"provisional"}]},"mentions":{"total":1,"shown":1,"rows":[{"url":"https://providers.uthscsa.edu/providers/john-sarantopoulos-1861495343/","platform":"other","status":"verified"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"recognition":{"education":{"total":2,"shown":2,"rows":[{"value":"MD","source_url":"https://providers.uthscsa.edu/providers/john-sarantopoulos-1861495343/","status":"verified","collected_at":"2026-10-27"},{"value":"Board certification: American Board of Internal Medicine/Medical Oncology; American Board of Internal Medicine","source_url":"https://providers.uthscsa.edu/providers/john-sarantopoulos-1861495343/","status":"verified","collected_at":"2026-10-27"}]},"roles":{"total":1,"shown":1,"rows":[{"value":"Member, early therapeutics and genitourinary committees, Southwest Oncology Group","source_url":"https://providers.uthscsa.edu/providers/john-sarantopoulos-1861495343/","status":"verified","collected_at":"2026-10-27"}]}},"contact":{"address_1":"7979 WURZBACH RD","city":"San Antonio","state":"TX","zip":"78229-4427","phone":"210-450-1000","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1861495343","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":5,"payments":37,"funding":7}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2010-08-18","collected_at":"2026-07-28"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-10-27"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-10-27"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward","collected_at":"2026-10-27"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year","collected_at":"2026-10-27"}},"methodology_url":"https://www.findmykol.com/about#methodology"}